Martin Shkreli is now the CEO of a publicly traded pharmaceutical company

Martin Shkreli is now the CEO of a publicly traded pharmaceutical company. In a release on Thursday, KaloBios named Shkreli CEO and chairman of the board while also adding three new board members. KaloBios saw its stock price rise more than 400% on Thursday after Shkreli and his associates reported that they'd purchased 70% of the company's outstanding shares earlier this week.
Read more: http://ift.tt/1OXNrRs